- Home
- BCG vs NTRB Comparison
BCG vs NTRB Comparison
Compare BCG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCG
- NTRB
- Stock Information
- Founded
- BCG 2016
- NTRB 2016
- Country
- BCG United States
- NTRB United States
- Employees
- BCG N/A
- NTRB N/A
- Industry
- BCG
- NTRB Industrial Specialties
- Sector
- BCG
- NTRB Health Care
- Exchange
- BCG Nasdaq
- NTRB Nasdaq
- Market Cap
- BCG 32.5M
- NTRB 71.8M
- IPO Year
- BCG N/A
- NTRB N/A
- Fundamental
- Price
- BCG $1.69
- NTRB $6.92
- Analyst Decision
- BCG
- NTRB Buy
- Analyst Count
- BCG 0
- NTRB 1
- Target Price
- BCG N/A
- NTRB $13.00
- AVG Volume (30 Days)
- BCG 24.3K
- NTRB 32.2K
- Earning Date
- BCG 11-13-2025
- NTRB 09-09-2025
- Dividend Yield
- BCG N/A
- NTRB N/A
- EPS Growth
- BCG N/A
- NTRB N/A
- EPS
- BCG N/A
- NTRB N/A
- Revenue
- BCG $173,961,000.00
- NTRB $2,578,059.00
- Revenue This Year
- BCG N/A
- NTRB $560.75
- Revenue Next Year
- BCG N/A
- NTRB $588.39
- P/E Ratio
- BCG N/A
- NTRB N/A
- Revenue Growth
- BCG 7.45
- NTRB 42.92
- 52 Week Low
- BCG $1.45
- NTRB $2.98
- 52 Week High
- BCG $6.55
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- BCG 41.63
- NTRB 53.45
- Support Level
- BCG $1.75
- NTRB $6.69
- Resistance Level
- BCG $2.10
- NTRB $7.48
- Average True Range (ATR)
- BCG 0.14
- NTRB 0.46
- MACD
- BCG -0.02
- NTRB 0.13
- Stochastic Oscillator
- BCG 36.92
- NTRB 66.51
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.